Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cushman & Wakefield | CWK | Jan 23, 2025 | 13.45 | +0.90 |
Custom Truck One Source | CTOS | Jan 23, 2025 | 5.37 | +6.13 |
Customers Bancorp | CUBI | Jan 23, 2025 | 50.35 | +0.44 |
Customers Bancorp E Pref | CUBI-E | Jan 23, 2025 | 25.65 | -0.31 |
Customers Bancorp F Pref | CUBI-F | Jan 23, 2025 | 25.60 | +0.46 |
Cutera | CUTR | Jan 23, 2025 | 0.44 | -4.93 |
CVB Financial | CVBF | Jan 23, 2025 | 20.66 | -0.15 |
CVD Equipment | CVV | Jan 23, 2025 | 3.59 | -0.28 |
CVR Energy | CVI | Jan 23, 2025 | 21.28 | +4.26 |
Cvr Partners LP Unit | UAN | Jan 23, 2025 | 82.36 | +0.98 |
CVRx | CVRX | Jan 23, 2025 | 18.13 | +5.35 |
CVS Health | CVS | Jan 23, 2025 | 53.82 | +1.57 |
CXApp A | CXAI | Jan 23, 2025 | 1.83 | -3.68 |
CyberArk Software | CYBR | Jan 23, 2025 | 358.93 | +0.08 |
Cybin | CYBN | Jan 23, 2025 | 10.19 | +1.80 |
Cyclacel Pharmaceuticals | CYCC | Jan 23, 2025 | 0.35 | -0.91 |
Cyclacel Pharmaceuticals Pref | CYCCP | Jan 23, 2025 | 6.95 | -7.33 |
Cyclerion Therapeutics | CYCN | Jan 23, 2025 | 2.92 | -1.19 |
Cyclo Therapeutics | CYTH | Jan 23, 2025 | 0.81 | +0.75 |
Cyngn | CYN | Jan 23, 2025 | 0.53 | -4.56 |
Cytek Biosciences | CTKB | Jan 23, 2025 | 5.69 | -1.39 |
Cytokinetics | CYTK | Jan 23, 2025 | 47.86 | +2.22 |
Cytomed Therapeutics | GDTC | Jan 23, 2025 | 2.47 | -3.14 |
CytomX Therapeutics | CTMX | Jan 23, 2025 | 0.87 | +3.57 |
Cytosorbents | CTSO | Jan 23, 2025 | 1.03 | +0.98 |
D-MARKET Electronic Services & Trading ADR | HEPS | Jan 23, 2025 | 3.06 | -3.16 |
D-Wave Quantum | QBTS | Jan 23, 2025 | 6.03 | -3.52 |
D.R. Horton | DHI | Jan 23, 2025 | 145.24 | -1.15 |
Dada Nexus ADR | DADA | Jan 23, 2025 | 1.36 | -1.45 |
Daily Journal | DJCO | Jan 23, 2025 | 474.50 | -1.79 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.